{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:02:45Z","timestamp":1793754165494,"version":"4.6.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Kaohsiung Medical University Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We aim\u00a0to investigate the role of medication adherence history in treatment needed diabetic retinopathy (TNDR). We conducted a retrospective nested case\u2013control study using 3 population-based databases in Taiwan. The major one was the 2-million-sample longitudinal health and welfare population-based database from 1997 to 2017, a nationally representative random sample of National Health Insurance Administration enrolled beneficiaries in 2010 (LHID2010). The national death registry and national cancer registry were also checked to verify the information. The outcome was defined as the TNDR. The Medication possession ratio (MPR) was defined as the ratio of total days of diabetes mellitus (DM) medication supply divided by total observation days. MPR\u2009\u2265\u200980% was proposed as good medication adherence. The association of MPR and the TNDR was analyzed. Other potential confounders and MPR ratio were also evaluated. A total of (n\u2009=\u200944,628) patients were enrolled. Younger aged, male sex and patients with less chronic illness complexity or less diabetes complication severity tend to have poorer medication adherence. Those with severe comorbidity or participating pay-for-performance program (P4P) revealed better adherence. No matter what the characteristics are, patients with good MPR showed a significantly lower likelihood of leading to TNDR after adjustment with other factors. The protection effect was consistent for up to 5\u00a0years. Good medication adherence significantly prevents treatment needed diabetic retinopathy. Hence, it is important to promote DM medication adherence to prevent risks of diabetic retinopathy progression, especially those who opt to have low medication adherence.<\/jats:p>","DOI":"10.1038\/s41598-021-98488-6","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T06:20:00Z","timestamp":1632723600000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Importance of medication adherence in treatment needed diabetic retinopathy"],"prefix":"10.1038","volume":"11","author":[{"given":"Chia-Chen","family":"Kao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3286-7306","authenticated-orcid":false,"given":"Hui-Min","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Pin","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2644-2475","authenticated-orcid":false,"given":"Shwu-Jiuan","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"issue":"6","key":"98488_CR1","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S2214-109X(13)70113-X","volume":"1","author":"RR Bourne","year":"2013","unstructured":"Bourne, R. R. et al. Causes of vision loss worldwide, 1990\u20132010: A systematic analysis. Lancet Glob. Health. 1(6), e339\u2013e349 (2013).","journal-title":"Lancet Glob. Health."},{"issue":"7258","key":"98488_CR2","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton, I. M. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 321(7258), 405\u2013412 (2000).","journal-title":"BMJ"},{"issue":"4","key":"98488_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5001\/omj.2012.68","volume":"27","author":"AB Olokoba","year":"2012","unstructured":"Olokoba, A. B., Obateru, O. A. & Olokoba, L. B. Type 2 diabetes mellitus: A review of current trends. Oman Med. J. 27(4), 269\u2013273 (2012).","journal-title":"Oman Med. J."},{"issue":"4","key":"98488_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4103\/0970-0218.91324","volume":"36","author":"P Vashist","year":"2011","unstructured":"Vashist, P., Singh, S., Gupta, N. & Saxena, R. Role of early screening for diabetic retinopathy in patients with diabetes mellitus: An overview. Indian J. Commun. Med. 36(4), 247\u2013252 (2011).","journal-title":"Indian J. Commun. Med."},{"issue":"6","key":"98488_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4093\/dmj.2014.38.6.416","volume":"38","author":"SJ Song","year":"2014","unstructured":"Song, S. J. & Wong, T. Y. Current concepts in diabetic retinopathy. Diabetes Metab. J. 38(6), 416\u2013425 (2014).","journal-title":"Diabetes Metab. J."},{"issue":"8","key":"98488_CR6","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1001\/jama.298.8.902","volume":"298","author":"Q Mohamed","year":"2007","unstructured":"Mohamed, Q., Gillies, M. C. & Wong, T. Y. Management of diabetic retinopathy: A systematic review. JAMA 298(8), 902\u2013916 (2007).","journal-title":"JAMA"},{"issue":"9","key":"98488_CR7","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.ophtha.2018.02.034","volume":"125","author":"A Obeid","year":"2018","unstructured":"Obeid, A. et al. Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections. Ophthalmology 125(9), 1386\u20131392 (2018).","journal-title":"Ophthalmology"},{"issue":"1","key":"98488_CR8","doi-asserted-by":"publisher","first-page":"e000429","DOI":"10.1136\/bmjdrc-2017-000429","volume":"5","author":"LK Lin","year":"2017","unstructured":"Lin, L. K., Sun, Y., Heng, B. H., Chew, D. E. K. & Chong, P. N. Medication adherence and glycemic control among newly diagnosed diabetes patients. BMJ Open Diabetes Res. Care 5(1), e000429 (2017).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"98488_CR9","doi-asserted-by":"publisher","first-page":"E88","DOI":"10.5888\/pcd14.170012","volume":"14","author":"H-M Hsieh","year":"2017","unstructured":"Hsieh, H.-M., He, J.-S., Shin, S.-J., Chiu, H.-C. & Lee, C.T.-C. A diabetes pay-for-performance program and risks of cancer incidence and death in patients with type 2 diabetes in Taiwan. Prev. Chronic Dis. 14, E88. https:\/\/doi.org\/10.5888\/pcd14.170012 (2017).","journal-title":"Prev. Chronic Dis."},{"issue":"2","key":"98488_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/app9020268","volume":"9","author":"S Cecilia","year":"2019","unstructured":"Cecilia, S., Florencia, P., Valeria, H. & Marcos, S. Relationship between continuity of care in the multidisciplinary treatment of patients with diabetes and their clinical results. Appl. Sci. 9(2), 268 (2019).","journal-title":"Appl. Sci."},{"issue":"6","key":"98488_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s40266-013-0074-z","volume":"30","author":"EL Sattler","year":"2013","unstructured":"Sattler, E. L., Lee, J. S. & Perri, M. 3rd. Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: A review of the literature. Drugs Aging. 30(6), 383\u2013399 (2013).","journal-title":"Drugs Aging."},{"issue":"4","key":"98488_CR12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.2337\/dc14-2098","volume":"38","author":"MS Kirkman","year":"2015","unstructured":"Kirkman, M. S. et al. Determinants of adherence to diabetes medications: Findings from a large pharmacy claims database. Diabetes Care 38(4), 604\u2013609 (2015).","journal-title":"Diabetes Care"},{"issue":"11","key":"98488_CR13","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1001\/jamaophthalmol.2016.3081","volume":"134","author":"Z Keenum","year":"2016","unstructured":"Keenum, Z. et al. Patients\u2019 adherence to recommended follow-up eye care after diabetic retinopathy screening in a publicly funded county clinic and factors associated with follow-up eye care use. JAMA Ophthalmol. 134(11), 1221\u20131228 (2016).","journal-title":"JAMA Ophthalmol."},{"issue":"1","key":"98488_CR14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1186\/s12913-018-3454-6","volume":"18","author":"SJ Sheu","year":"2018","unstructured":"Sheu, S. J., Lin, W. L., Kao Yang, Y. H., Hwu, C. M. & Cheng, C. L. Pay for performance program reduces treatment needed diabetic retinopathy: A nationwide matched cohort study in Taiwan. BMC Health Serv. Res. 18(1), 638 (2018).","journal-title":"BMC Health Serv. Res."},{"issue":"12","key":"98488_CR15","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1097\/IAE.0000000000001892","volume":"38","author":"M Weiss","year":"2018","unstructured":"Weiss, M. et al. Compliance and adherence of patients with diabetic macular edema to intravitreal anti-vascular endothelial growth factor therapy in daily practice. Retina 38(12), 2293\u20132300 (2018).","journal-title":"Retina"},{"issue":"2","key":"98488_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/2374373519831073","volume":"7","author":"S Badi","year":"2020","unstructured":"Badi, S., Abdalla, A., Altayeb, L., Noma, M. & Ahmed, M. H. Adherence to antidiabetic medications among sudanese individuals with type 2 diabetes mellitus: A cross-sectional survey. J. Patient Exp. 7(2), 163\u2013168 (2020).","journal-title":"J. Patient Exp."},{"issue":"3","key":"98488_CR17","first-page":"159","volume":"9","author":"MM Rana","year":"2019","unstructured":"Rana, M. M., Islam, M. S., Akter, J. & Khatun, S. Medication Adherence to type 2 diabetic patients hospitalized at a tertiary care hospital in bangladesh: Diabetic medication adherence. J. Health Sci. 9(3), 159\u2013167 (2019).","journal-title":"J. Health Sci."},{"issue":"1","key":"98488_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.diabres.2011.11.003","volume":"96","author":"KN van Eijk","year":"2012","unstructured":"van Eijk, K. N., Blom, J. W., Gussekloo, J., Polak, B. C. & Groeneveld, Y. Diabetic retinopathy screening in patients with diabetes mellitus in primary care: Incentives and barriers to screening attendance. Diabetes Res. Clin. Pract. 96(1), 10\u201316 (2012).","journal-title":"Diabetes Res. Clin. Pract."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98488-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98488-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98488-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T11:09:01Z","timestamp":1670065741000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98488-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98488"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98488-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,27]]},"assertion":[{"value":"19 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19100"}}